CordovaCann Corp (LVRLF) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of CordovaCann Corp stock $0.033, price $0.03, upside +10.0%, quality 57 out of 100. Rating: fairly valued. Calculated from audited financials with 12 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
CordovaCann Corp
LVRLF · USSolid company, but the stock is already about fairly priced.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
60‑month range $0.03 – $2.30 · fair‑value band $0.03 – $0.036 · the $0.03 price screens below the $0.033 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 3 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 5, 2026.
Every Wednesday you see whether CordovaCann is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
CordovaCann Corp. engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.
Show moreShow less
The company was formerly known as LiveReel Media Corporation and changed its name to CordovaCann Corp. in January 2018. CordovaCann Corp. was founded in 1997 and is headquartered in Toronto, Canada.
Stock analysis
CordovaCann Corp (LVRLF) currently trades at $0.03, while our model-based Fair Value estimate is $0.033, so the stock looks roughly fairly valued today (gap 9.1%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $0.095 per share, and 9 of the 12 models we run sit above the $0.03 price.
Bear case: the Earnings-Based group reads lowest at $0.03, and 3 of the 12 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.03 (bear) to $0.036 (bull), the price of $0.03 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CordovaCann Corp reported revenue of C$13.4M in FY2026 versus C$13.5M in FY2022, a compound −0.3%/yr. Reported net income was −C$1.5M in FY2026.
Key figures
Market cap $3.3M Micro · P/S ratio 0.25 · EPS (TTM) $-0.01 · Net margin −11.2% · Return on equity −531% · Return on assets (EBIT) −9.4% (5-year average) · Operating margin 2.5% · Revenue (TTM) C$13.4M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (medium confidence).
What moves the price
The share trades about 57% below its 52-week high and 500% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at 10%, LVRLF screens cheaper than that median.
Fair Value models
All 12 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch LVRLF, get fair value alerts →
Compare CordovaCann Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 610 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $79.11 | $113.53 | +44% | vs LVRLF |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥47.00 | ¥52.43 | +12% | vs LVRLF |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,884.90 | ₹1,982.92 | +5% | vs LVRLF |
| Haleon plc HLN | $9.07 | $8.47 | −7% | vs LVRLF |
| Merck KGaA MRK | €146.45 | €108.83 | −26% | vs LVRLF |
| Galderma Group GALD | CHF 182.85 | CHF 112.84 | −38% | vs LVRLF |
| Teva Pharmaceutical Industries Limited TEVA | $39.23 | $20.74 | −47% | vs LVRLF |
| Takeda Pharmaceutical Company TAK | $21.77 | $11.26 | −48% | vs LVRLF |
| Sandoz Group SDZ | CHF 80.50 | CHF 41.06 | −49% | vs LVRLF |
| Divi's Laboratories Limited DIVISLAB | ₹11,180.50 | ₹1,566.89 | −86% | vs LVRLF |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is CordovaCann Corp (LVRLF) overvalued or undervalued?
What is the fair value of LVRLF?
What is the quality score of LVRLF?
What is the price target for CordovaCann Corp (LVRLF)?
What is the CordovaCann Corp stock forecast for 2026?
What is the revenue of CordovaCann Corp (LVRLF)?
What growth is priced into CordovaCann Corp (LVRLF)?
What discount rate (WACC) does the fair value of LVRLF use?
What is a reverse DCF?
How much growth has CordovaCann Corp (LVRLF) delivered so far?
How fast is the sector of CordovaCann Corp (LVRLF) growing?
What is the free cash flow yield of CordovaCann Corp (LVRLF)?
What is the intrinsic value of CordovaCann Corp (LVRLF)?
Is CordovaCann Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LVRLF?
How much is CordovaCann Corp worth?
What do the bullish and bearish scenarios say about LVRLF?
How solid is the balance sheet of CordovaCann Corp (LVRLF)?
How far is LVRLF from its 52-week high?
Which stocks are comparable to CordovaCann Corp?
Is CordovaCann Corp stock attractive at the current price?
How is the fair value of LVRLF calculated?
Is it still worth investing in stocks now?
What is the share price of CordovaCann Corp (LVRLF)?
What should I pay attention to with CordovaCann Corp right now?
Key figures of CordovaCann Corp
How large is the market capitalisation of CordovaCann Corp (LVRLF)?
What is the P/S ratio of CordovaCann Corp (LVRLF)?
What are the earnings per share of CordovaCann Corp (LVRLF)?
What is the net margin of CordovaCann Corp (LVRLF)?
What is the return on equity of CordovaCann Corp (LVRLF)?
What is the EBIT return on assets of CordovaCann Corp (LVRLF)?
What is the operating margin of CordovaCann Corp (LVRLF)?
How fast is revenue growing at CordovaCann Corp (LVRLF)?
How much net debt does CordovaCann Corp (LVRLF) carry?
Watch CordovaCann Corp in the live analysis
One click puts CordovaCann Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.